Rivaroxaban

BH3 interacting domain death agonist ; Homo sapiens







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33704609 Prevention and Management of Urgent/Emergent Limb Ischemia. 2021 Mar 11 1
2 32323191 Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism. 2020 Jul 1
3 30058959 Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial. 2019 Apr 1
4 30839367 Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances. 2019 Mar/Apr 3
5 30340765 Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial). 2018 Dec 1 4
6 28418370 [Current study aimed to highlight extent of clot resolution in deep veins and its association with anticoagulation pattern in VTE patients]. 2017 1
7 25419161 A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban. 2014 1